Cargando…
The efficacy and safety of fingolimod plus standardized treatment versus standardized treatment alone for acute ischemic stroke: A systematic review and meta‐analysis
Acute ischemic stroke (AIS) is the most common type of stroke. Fingolimod is a sphingosine analog that acts on sphingosine‐1‐phosphate receptors (S1PR). Recently, the safety and efficacy of fingolimod in both patients with intracerebral hemorrhage and patients with AIS have been investigated in proo...
Autores principales: | Bai, Peng, Zhu, Runxiu, Wang, Ping, Jiang, Feng, Zhen, Jin, Yao, Yuan, Zhao, Chenhui, Liang, Zihong, Wang, Meiling, Liu, Bin, Li, Min, Li, Na, Yuan, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117458/ https://www.ncbi.nlm.nih.gov/pubmed/35585652 http://dx.doi.org/10.1002/prp2.972 |
Ejemplares similares
-
Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke
por: Li, Wentao, et al.
Publicado: (2016) -
Could Lipoxins Represent a New Standard in Ischemic Stroke Treatment?
por: Tułowiecka, Nikola, et al.
Publicado: (2021) -
Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022) -
A study on endovascular treatment alone and bridging treatment for acute ischemic stroke
por: Ji, Xiyang, et al.
Publicado: (2023) -
Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients
por: Salem, Gelan M., et al.
Publicado: (2021)